Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	21.22B
Revenue (ttm)	898.73M
Net Income (ttm)	133.75M
Shares Out	65.86M
EPS (ttm)	2.01
PE Ratio	160.30
Forward PE	69.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,814
Average Volume	177,102
Open	329.20
Previous Close	329.20
Day's Range	321.40 - 332.00
52-Week Range	216.20 - 405.80
Beta	0.91
RSI	40.83
Earnings Date	Feb 25, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft sub...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 135
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.